Genetic Mutations and Family History
662 articles
Reaching Primary Care Providers Through Podcasts
Dr. Jon Hallberg leads a series on early detection of pancreatic cancer as part of his mission to reach providers through podcasts.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.
Questions to Ask Before You Begin Chemotherapy
Do you want to better understand your pancreatic cancer treatment? Dr. Andrew Hendifar outlines important questions to ask before starting chemotherapy.
CRISPR: A New Tool to Help Understand Cancer-Linked Mutations
Lukas Dow, Ph.D., is using CRISPR technology to find better ways to fight cancer by editing the genome.
Research and Other Highlights from the 2023 AACR Annual Meeting
The 2023 AACR meeting focused on the latest research into KRAS, other immunotherapy approaches, and honored Dr. Elizabeth Jaffee.
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
Symptoms and Risk Factors
Moderator Daniel G Garza leads Dr. Rachna Shroff and Dr. Fiyinfolu Balogun in a discussion of risk factors and symptoms of pancreatic cancer.
Newly Diagnosed
What to Do If You Are Newly Diagnosed with Pancreatic Cancer You or someone you love has been diagnosed with pancreatic cancer. Now what? First, take a breath and know that you are not alone in this overwhelming moment. Let’s Win has the most up-to-date information, research, and resources to help you make informed decisions […]
ASCO Annual Conference: Highlights in Pancreatic Cancer Research
Dr. Allyson Ocean reviews some of the latest pancreatic cancer research results, including new treatments for some patients.
Developing a Screening Test for Pancreatic Cancer
One focus of research for Dr. Anirban Maitra is to develop a simple screening test for pancreatic cancer, to provide an earlier diagnosis of the disease.
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.